Ken Fujioka
Publications by Year
Research Areas
Pharmacology and Obesity Treatment, Diabetes Treatment and Management, Diet and metabolism studies, Metabolism, Diabetes, and Cancer, Bariatric Surgery and Outcomes
Most-Cited Works
- → A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management(2015)2,485 cited
- → Recombinant Leptin for Weight Loss in Obese and Lean Adults(1999)1,422 cited
- → Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial(2010)1,001 cited
- → 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial(2017)824 cited
- → Effects of Naltrexone Sustained- Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes(2013)483 cited
- → Rational Design of a Combination Medication for the Treatment of Obesity(2008)342 cited
- → Bupropion SR Enhances Weight Loss: A 48‐Week Double‐Blind, Placebo‐ Controlled Trial(2002)317 cited
- → Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study(1999)289 cited
- → Follow-up of Nutritional and Metabolic Problems After Bariatric Surgery(2005)259 cited
- → Efficacy and Safety of Sibutramine in Obese White and African American Patients With Hypertension(2000)247 cited